These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7773536)

  • 1. Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats.
    Mathôt RA; Cleton A; Soudijn W; IJzerman AP; Danhof M
    Br J Pharmacol; 1995 Feb; 114(4):761-8. PubMed ID: 7773536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.
    Mathôt RA; Gubbens-Stibbe JM; Soudijn W; Jacobson KA; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1995 Oct; 275(1):245-53. PubMed ID: 7562557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adenosine A2A receptor agonist, CGS 21680, on blood pressure, cardiac index and arterial conductance in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Eur J Pharmacol; 1996 Jun; 307(2):163-9. PubMed ID: 8832218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
    Webb RL; Barclay BW; Graybill SC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
    Webb RL; Sills MA; Chovan JP; Peppard JV; Francis JE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):287-95. PubMed ID: 8229754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo.
    Mathoôt RA; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
    Br J Pharmacol; 1996 May; 118(2):369-77. PubMed ID: 8735640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonism of the nonselective adenosine receptor agonist 8-butylaminoadenosine at the A1 receptor in vivo.
    Mathot RA; Wenden EM; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1439-46. PubMed ID: 8968369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic modelling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N6-(p-sulphophenyl)adenosine in rats.
    van Schaick EA; de Greef HJ; Langemeijer MW; Sheehan MJ; IJzerman AP; Danhof M
    Br J Pharmacol; 1997 Oct; 122(3):525-33. PubMed ID: 9351510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo.
    Mathôt RA; Van der Wenden EM; Soudijn W; IJzerman AP; Danhof M
    Br J Pharmacol; 1995 Oct; 116(3):1957-64. PubMed ID: 8640332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanisms by which adenosine induces vasodilatation in rat skeletal muscle: significance for systemic hypoxia.
    Bryan PT; Marshall JM
    J Physiol; 1999 Jan; 514 ( Pt 1)(Pt 1):163-75. PubMed ID: 9831724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline.
    Appel S; Mathôt RA; Langemeijer MW; IJzerman AP; Danhof M
    Br J Pharmacol; 1995 Aug; 115(7):1253-9. PubMed ID: 7582553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
    Hutchison AJ; Webb RL; Oei HH; Ghai GR; Zimmerman MB; Williams M
    J Pharmacol Exp Ther; 1989 Oct; 251(1):47-55. PubMed ID: 2795469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat.
    Mathôt RA; van Schaick EA; Langemeijer MW; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1994 Feb; 268(2):616-24. PubMed ID: 8113972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat.
    Fozard JR; Ellis KM; Villela Dantas MF; Tigani B; Mazzoni L
    Eur J Pharmacol; 2002 Mar; 438(3):183-8. PubMed ID: 11909610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
    Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR
    Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle.
    Bokník P; Neumann J; Schmitz W; Scholz H; Wenzlaff H
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):750-8. PubMed ID: 9436814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism and pressor relevance of the short-term cardiovascular and renin excitatory actions of the selective A2A-adenosine receptor agonists.
    Alberti C; Monopoli A; Casati C; Forlani A; Sala C; Nador B; Ongini E; Morganti A
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):320-4. PubMed ID: 9300315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8-Alkylamino-substituted analogs of N6-cyclopentyladenosine are partial agonists for the cardiovascular adenosine A1 receptors in vivo.
    Van Schaick EA; Math-ot RA; Gubbens-Stibbe JM; Langemeijer MW; Roelen HC; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1997 Nov; 283(2):800-8. PubMed ID: 9353401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.